FDA Approves New Antibiotic for Complicated Urinary Tract Infections

The FDA has granted approval for Wockhardt's ZAYNICH, an intravenous antibiotic combining cefepime and zidebactam, to treat complicated urinary tract infections in adults. This new therapeutic option is specifically for infections caused by susceptible Gram-negative pathogens, including pyelonephritis. The approval addresses a critical need for effective treatments against aggressive, drug-resistant infections.